Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer

被引:57
|
作者
Pinaquy, Jean-Baptiste [1 ]
De Clermont-Galleran, Henri [1 ,2 ]
Pasticier, Gilles [3 ]
Rigou, Gerald [4 ]
Alberti, Nicolas [4 ]
Hindie, Elif [1 ,2 ]
Mokrane, Yacoub [5 ]
Fernandez, Philippe [1 ,2 ]
机构
[1] Hop Pellegrin, Dept Nucl Med, F-33076 Bordeaux, France
[2] Univ Bordeaux, INCIA, UMR CNRS 5287, Bordeaux, France
[3] Hop Pellegrin, Dept Urol, F-33076 Bordeaux, France
[4] Hop Pellegrin, Dept Radiol, F-33076 Bordeaux, France
[5] Hop Pellegrin, Dept Pathol, F-33076 Bordeaux, France
关键词
F-18]-fluorocholine; DWI; MRI; prostate cancer; staging; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LYMPH-NODES; RADICAL PROSTATECTOMY; LOCALIZATION; INTERMEDIATE; NOMOGRAM; DISEASE;
D O I
10.1002/pros.22921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Accurate staging is important before surgical decision in patients with high-risk prostate cancer (PCa). The purpose of this study was to prospectively compare the diagnostic performance of F-18-FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND). METHODS. We identified 47 patients who underwent F-18-FCholine and DWIMRI followed by surgical treatment (either prostatectomy or LN dissection or an association of prostatectomy and LN dissection) between May 2010 and December 2012 at Bordeaux University Hospital. These patients were part of a prospective study (EudraCT number 2009-014839-21) evaluating the interest of F-18-FCholine in staging of high-risk PCa. Diagnostic performances were retrospectively determined for each of F-18-FCholine and DWIMRI considering LN invasion, each of prostate sextants, capsular invasion and extension to seminal vesicles. F-18-FCholine and MR findings were correlated with histological findings. RESULTS. In a region-based LN analysis, the sensitivity and positive predictive value specificity were respectively, 56% and 98% for F-18-Choline, and 17% and 97% for DWIMRI. In a patient-based analysis the sensitivity and positive predictive value were respectively 78% and 94% for F-18-Choline and 33% and 84% for DWIMRI (P = 0.015). For tumor staging, DWIMRI showed better performances with a better specificity (69%) for sextants analysis and sensitivity to detect seminal vesicle invasion (73% vs. 36%). CONCLUSIONS. F-18-FCholine imaging appears to provide helpful additional information in the staging of high-risk PCa. It appears essential for predicting LN status due to its higher sensitivity and specificity for LN involvement. However, despite excellent performance, it cannot replace MRI that remains better for tumoral localization and local evaluation, especially for seminal vesicle invasion. PATIENT SUMMARY. This study highlights the interest of F-18-Choline in the staging of high risk prostate cancer in addition with DWI MRI, especially so in the evaluation of lymph node involvement due to its high sensitivity and excellent specificity. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [31] Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
    Rodriguez-Pajuelo, Ana
    Guerra-Gomez, Miriam
    Cuenca, Juan Ignacio Cuenca
    Freire-Macias, Jose Maria
    Garcia, Jose Manuel Jimenez-Hoyuela
    alvarez-Perez, Rosa Maria
    EJNMMI REPORTS, 2025, 9 (01)
  • [32] [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse:: experience in 100 consecutive patients
    Cimitan, Marino
    Bortolus, Roberto
    Morassut, Sandro
    Canzonieri, Vincenzo
    Garbeglio, Antonio
    Baresic, Tanja
    Borsatti, Eugenio
    Drigo, Annalisa
    Trovo, Mauro G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (12) : 1387 - 1398
  • [33] [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
    Lucia Zanoni
    Lorenzo Bianchi
    Cristina Nanni
    Cristian Pultrone
    Francesca Giunchi
    Irene Bossert
    Antonella Matti
    Riccardo Schiavina
    Michelangelo Fiorentino
    Daniele Romagnoli
    Cristina Fonti
    Filippo Lodi
    Antonietta D’Errico
    Eugenio Brunocilla
    Angelo Porreca
    Stefano Fanti
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 49 : 390 - 409
  • [34] Role of 18F-Choline PET/CT in the Initial Staging of High Risk Prostate Cancer and Comparison with Conventional Imaging Techniques
    Sutil, Raquel Sopena
    Grande, Adolfo Gomez
    Diaz, Alejandro Gonzalez
    Tobar, Julio Teigel
    Rodriguez, Maria Angeles Cabeza
    Billalabeitia, Enrique Gonzalez
    Antolin, Alfredo Rodriguez
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (08): : 684 - 692
  • [35] Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
    Jacob Ingvar
    Erland Hvittfeldt
    Elin Trägårdh
    Athanasios Simoulis
    Anders Bjartell
    EJNMMI Research, 12
  • [36] Utility of PET/CT with [18F] F-fluorocholine in assessing the response to antiandrogenic therapy in patients with prostate cancer
    Quintero, K.
    Vila, E.
    Ferrer-Mileo, L.
    Vas, D.
    Ribal, Maria J.
    Garcia-Herreros, M.
    Navarro, N.
    Tormo-Ratera, M.
    Aversa, C.
    Vilaseca, A.
    Farre-Melero, A.
    Fuster, D.
    Paredes, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (02):
  • [37] Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
    Owens, R. Grant
    Loloi, Justin
    Lehman, Erik B.
    Kaag, Matthew G.
    Raman, Jay D.
    Merrill, Suzanne B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (07) : 433.e9 - 433.e15
  • [38] [18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
    Nault, Jean-Charles
    Boubaya, Marouane
    Wartski, Myriam
    Dohan, Anthony
    Pol, Stanislas
    Pop, Gabriel
    Soussan, Michael
    Sutter, Olivier
    Costentin, Charlotte
    Roux, Julie
    Sengel, Christian
    Lequoy, Marie
    Montravers, Francoise
    Menu, Yves
    Pageaux, Georges-Philippe
    Goulart, Denis Mariano
    Guiu, Boris
    Luciani, Alain
    Nahon, Pierre
    Burgio, Marco Dioguardi
    Wagner, Mathilde
    Maksud, Philippe
    Mule, Sebastien
    Allaire, Manon
    Sidali, Sabrina
    Coilly, Audrey
    Besson, Florent L.
    Lewin, Maite
    Regnault, Helene
    Hollande, Clemence
    Amaddeo, Giuliana
    Ronot, Maxime
    Ganne-Carrie, Nathalie
    Itti, Emmanuel
    Bloch-Queyrat, Coralie
    Levy, Vincent
    Lebtahi, Rachida
    Chalaye, Julia
    Bouattour, Mohamed
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (04): : 306 - 314
  • [39] Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT
    Cerny, Milena
    Dunet, Vincent
    Prior, John Olivier
    Hahnloser, Dieter
    Wagner, Anna Dorothea
    Meuli, Reto Antoine
    Schmidt, Sabine
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (04) : 289 - 295
  • [40] Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
    Husarik, Daniela B.
    Miralbell, Raymond
    Dubs, Markus
    John, Hubert
    Giger, Olivier T.
    Gelet, Albert
    Cservenyak, Tibor
    Hany, Thomas F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) : 253 - 263